European Archives - Page 474 of 1104 - European Medical Journal

Crohn’s Disease Inflammation Exacerbated by E. coli

A study discovered that intestinal inflammation in Crohn’s disease frees up chemicals, which nourish the growth of bacteria, such as E. coli.

Climate Change and Human Health - Pollution and Respiratory Diseases

Jonathan Samet discusses the impact of climate change on healthcare, with regard to the links between pollutants and respiratory conditions.

Could Early Screening Reduce Risk of Developing Colorectal Cancer?

Screening for colorectal cancer (CRC) could significantly reduce risk in females if carried out before the age of 50 years…

Acute Myeloid Leukemia

Jazz-Sponsored Symposium - High-risk AML* in 2022: what is the go-to strategy?

*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)

Diabetic Ketoacidosis Precipitated by COVID-19: A Case Report

A 55-year-old African American female presented to her primary care physician (PCP), complaining of fatigue, dehydration, decreased…

Study Uncovers Mechanisms of COVID-19-Mediated Platelet Activation

A pivotal study has uncovered the mechanisms behind the hyperactivation of platelets during a SARS-CoV-2 infection…

EMA Recommends Gene Therapy for Treatment of Multiple Myeloma

Innovative personalised gene therapy for the treatment of multiple myeloma has been recommended by EMA. Read to find out more…

GSK’s John Wahba on the evolution of medical affairs

John Wahba, Medical Head of the Global Digital Hub, GSK, talks about how collaboration and teamwork will drive change in pharma, his views on digital and omnichannel optimisation and his passion for patient empowerment

EFPIA endorses European Health Data Space

EFPIA has announced its support for the European Health Data Space, a health-specific ecosystem that increases access to electronical health records to individuals. Read more

Social sustainability, patient advocacy and policy campaigning

In this episode, Marc and Helena are joined by Leo Pharma’s Klaus League to discuss social sustainability, patient advocacy and policy campaigning.